Article thumbnail

Genetic Variation of the Human α-2-Heremans-Schmid Glycoprotein (AHSG) Gene Associated with the Risk of SARS-CoV Infection

By Xiaohui Zhu, Yan Wang, Hongxing Zhang, Xuan Liu, Ting Chen, Ruifu Yang, Yuling Shi, Wuchun Cao, Ping Li, Qingjun Ma, Yun Zhai, Fuchu He, Gangqiao Zhou and Cheng Cao

Abstract

Genetic background may play an important role in the process of SARS-CoV infection and SARS development. We found several proteins that could interact with the nucleocapsid protein of the SARS coronavirus (SARS-CoV). α-2-Heremans-Schmid Glycoprotein (AHSG), which is required for macrophage deactivation by endogenous cations, is associated with inflammatory regulation. Cytochrome P450 Family 3A (CYP4F3A) is an ω-oxidase that inactivates Leukotriene B4 (LTB4) in human neutrophils and the liver. We investigated the association between the polymorphisms of these two inflammation-associated genes and SARS development. The linkage disequilibrium (LD) maps of these two genes were built with Haploview using data on CHB+JPT (version 2) from the HapMap. A total of ten tag SNPs were selected and genotyped. In the Guangzhou cohort study, after adjusting for age and sex, two AHSG SNPs and one CYP4F3 SNP were found to be associated with SARS susceptibility: rs2248690 (adjusted odds ratio [AOR] 2.42; 95% confidence interval [CI] 1.30-4.51); rs4917 (AOR 1.84; 95% CI 1.02-3.34); and rs3794987 (AOR 2.01; 95% CI 1.10–3.68). To further validate the association, the ten tag SNPs were genotyped in the Beijing cohort. After adjusting for age and sex, only rs2248690 (AOR, 1.63; 95% CI, 1.30–2.04) was found to be associated with SARS susceptibility. The combined analysis of the two studies confirmed tag SNP rs2248690 in AHSG as a susceptibility variant (AOR 1.70; 95% CI 1.37–2.09). The statistical analysis of the rs2248690 genotype data among the patients and healthy controls in the HCW cohort, who were all similarly exposed to the SARS virus, also supported the findings. Further, the SNP rs2248690 affected the transcriptional activity of the AHSG promoter and thus regulated the AHSG serum level. Therefore, our study has demonstrated that the AA genotype of rs2268690, which leads to a higher AHSG serum concentration, was significantly associated with protection against SARS development

Topics: Research Article
Publisher: Public Library of Science
OAI identifier: oai:pubmedcentral.nih.gov:3163911
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (2011). A hepatic protein, fetuin-A, occupies a protective role in lethal systemic inflammation.
  2. (2003). A novel coronavirus associated with severe acute respiratory syndrome.
  3. (2008). A promoter polymorphism of the alpha2-HS glycoprotein gene is associated with its transcriptional activity.
  4. (2002). Amplification of extracellular nucleotide-induced leukocyte(s) degranulation by contingent autocrine and paracrine mode of leukotrienemediated chemokine receptor activation.
  5. (2005). Association between mannose-binding lectin gene polymorphisms and susceptibility to severe acute respiratory syndrome coronavirus infection.
  6. (2005). Association of alpha2-HS glycoprotein (AHSG, fetuin-A) polymorphism with AHSG and phosphate serum levels.
  7. (2003). Association of HLA class I with severe acute respiratory syndrome coronavirus infection.
  8. (2004). Association of human-leukocyte-antigen class I (B*0703) and class II (DRB1*0301) genotypes with susceptibility and resistance to the development of severe acute respiratory syndrome.
  9. (2006). Association of SARS susceptibility with single nucleic acid polymorphisms of OAS1 and MxA genes: a case-control study.
  10. (2005). Asymptomatic SARS coronavirus infection among healthcare workers,
  11. (2007). Biosynthesis and metabolism of leukotrienes.
  12. (1999). Control of cell cycle progression by c-Jun is p53 dependent.
  13. (2003). Coronavirus as a possible cause of severe acute respiratory syndrome.
  14. (2007). Decreased levels of circulating alpha2-Heremans-Schmid glycoprotein/Fetuin-A (AHSG) in patients with rheumatoid arthritis.
  15. (2003). Diagnosis of severe acute respiratory syndrome (SARS) by detection of SARS coronavirus nucleocapsid antibodies in an antigen-capturing enzyme-linked immunosorbent assay.
  16. (1992). Diagnostic value of the determination of serum a2-HS-glycoprotein concentration. Orv Hetil 133:
  17. (1998). Fetuin (alpha2-HS-glycoprotein) opsonizes cationic macrophagedeactivating molecules.
  18. (2001). Fetuin, a negative acute phase protein, attenuates TNF synthesis and the innate inflammatory response to carrageenan.
  19. (2006). Homozygous L-SIGN (CLEC4M) plays a protective role in SARS coronavirus infection.
  20. (2007). Identification and characterization of dominant helper T-cell epitopes in the nucleocapsid protein of severe acute respiratory syndrome coronavirus.
  21. (2003). Identification of a novel coronavirus in patients with severe acute respiratory syndrome.
  22. (2004). Induction of SARS-nucleoprotein-specific immune response by use of DNA vaccine.
  23. (2008). Lack of association between HLA-A, -B and -DRB1 alleles and the development of SARS: a cohort of 95 SARS-recovered individuals in a population of Guangdong,
  24. (2007). Lack of support for an association between CLEC4M homozygosity and protection against SARS coronavirus infection. Nat Genet 39: 691–692; author reply 694-696.
  25. (2007). Lack of support for an association between CLEC4M homozygosity and protection against SARS coronavirus infection. Nat Genet 39: 692–694; author reply
  26. (2005). Mannosebingding lectin in severe acute respiratory syndrome coronavirus infection.
  27. (2004). Mild illness associated with severe acute respiratory syndrome coronavirus infection: lessons from a prospective seroepidemiologic study of health-care workers in a teaching hospital in Singapore.
  28. (2003). Mild severe acute respiratory syndrome.
  29. (1988). Modifications of concanavalin A patterns of A1-acid-glyco-protein and a2-HS-glycoprotein in alcoholic liver disease.
  30. (1997). Molecular evidence for human alpha 2-HS glycoprotein (AHSG) polymorphism.
  31. (2008). Prior immunization with severe acute respiratory syndrome (SARS)-associated coronavirus (SARS-CoV) nucleocapsid protein causes severe pneumonia in mice infected with SARS-CoV.
  32. (2004). Profile of antibodies to the nucleocapsid protein of the severe acute respiratory syndrome (SARS)-associated coronavirus in probable SARS patients.
  33. (2004). Relative rates of non-pneumonic SARS coronavirus infection and SARS coronavirus pneumonia.
  34. (2004). SARS exposure and emergency department workers.
  35. (1991). Serum alpha 2-HS glycoprotein concentration in patients with hematological malignancies. A follow-up study.
  36. (1979). Serum concentration of human alpha 2 HS glycoprotein during the inflammatory process: evidence that alpha 2 HS glycoprotein is a negative acute-phase reactant.
  37. (2007). The association of RANTES polymorphism with severe acute respiratory syndrome in Hong Kong and Beijing Chinese.
  38. (2006). The interferon gama gene polymorphism +874 A/T is associated with severe acute respiratory syndrome.
  39. (2008). The nucleocapsid protein of severe acute respiratory syndrome coronavirus inhibits cell cytokinesis and proliferation by interacting with translation elongation factor 1alpha.
  40. (1995). Two serum response elements mediate transcriptional repression of human smooth muscle alpha-actin promoter in ras-transformed cells.